Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
Research output: Contribution to journal › Comment/debate › Research › peer-review
Standard
Correction to : Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial. / Ott, Caroline Vintergaard; Vinberg, Maj; Bowie, Christopher R.; Christensen, Ellen Margrethe; Knudsen, Gitte Moos; Kessing, Lars Vedel; Miskowiak, Kamilla Woznica.
In: Trials, Vol. 20, No. 1, 201, 08.04.2019.Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Correction to
T2 - Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
AU - Ott, Caroline Vintergaard
AU - Vinberg, Maj
AU - Bowie, Christopher R.
AU - Christensen, Ellen Margrethe
AU - Knudsen, Gitte Moos
AU - Kessing, Lars Vedel
AU - Miskowiak, Kamilla Woznica
N1 - Correction to: Trials (2018) 19:487 https://doi.org/10.1186/s13063-018-2860-8
PY - 2019/4/8
Y1 - 2019/4/8
N2 - Following publication of the original article [1], the authors notified us that a comment in the Peripheral and neural biomarkers and genotype section was incorrectly phrased during editing. "4 weeks of treatment (four active ABCR sessions twice a week or control group sessions twice a week)" should have actually been described as "4 weeks of treatment (4 active, twice a week, ABCR sessions or 2 weekly control group sessions)".
AB - Following publication of the original article [1], the authors notified us that a comment in the Peripheral and neural biomarkers and genotype section was incorrectly phrased during editing. "4 weeks of treatment (four active ABCR sessions twice a week or control group sessions twice a week)" should have actually been described as "4 weeks of treatment (4 active, twice a week, ABCR sessions or 2 weekly control group sessions)".
U2 - 10.1186/s13063-019-3289-4
DO - 10.1186/s13063-019-3289-4
M3 - Comment/debate
C2 - 30961672
AN - SCOPUS:85064122881
VL - 20
JO - Trials
JF - Trials
SN - 1745-6215
IS - 1
M1 - 201
ER -
ID: 226489627